Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714242
Status:
COMPLETED
Last Update Posted:
2021-01-19
First Post:
2021-01-14
Brief Title:
OCTA and Polypoidal Choroidal Vasculopathy
Sponsor:
Federico II University
Organization:
Federico II University
Study Overview
Official Title:
Choroid and Choriocapillary Changes in Polypoidal Choroidal Vasculopathy After Intravitreal Anti-VEGF Therapy
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the structural and vascular features of choroid in patients affected by PCV after Ranibizumab intravitreal injection
Detailed Description:
Polypoidal choroidal vasculopathy represents a distinct form of choroidal neovascularization
The study investigated the changes in choroidal vascular network after anti-VEGF therapy using optical coherence tomography angiography a novel and non invasive diagnostic technique that allows to better understand the pathophysiologic mechanism of this neovascularization
The study investigated the changes in choroidal vascular network after anti-VEGF therapy using optical coherence tomography angiography a novel and non invasive diagnostic technique that allows to better understand the pathophysiologic mechanism of this neovascularization
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None